BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30643192)

  • 1. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
    Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E74-like Factor 5 Promoter Methylation in Circulating Tumor DNA as a Potential Prognostic Marker in Breast Cancer Patients.
    Salimi M; Rastegarpouyani S
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4035-4041. PubMed ID: 38156835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of
    Vagionas A; Balgkouranidou I; Koukaki T; Biziota E; Amarantidis K; Kakolyris S; Xenidis N
    Hippokratia; 2023; 27(1):7-11. PubMed ID: 38533226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation patterns in serum DNA for early identification of disseminated breast cancer.
    Widschwendter M; Evans I; Jones A; Ghazali S; Reisel D; Ryan A; Gentry-Maharaj A; Zikan M; Cibula D; Eichner J; Alunni-Fabbroni M; Koch J; Janni WJ; Paprotka T; Wittenberger T; Menon U; Wahl B; Rack B; Lempiäinen H
    Genome Med; 2017 Dec; 9(1):115. PubMed ID: 29268762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
    Liu L; Toung JM; Jassowicz AF; Vijayaraghavan R; Kang H; Zhang R; Kruglyak KM; Huang HJ; Hinoue T; Shen H; Salathia NS; Hong DS; Naing A; Subbiah V; Piha-Paul SA; Bibikova M; Granger G; Barnes B; Shen R; Gutekunst K; Fu S; Tsimberidou AM; Lu C; Eng C; Moulder SL; Kopetz ES; Amaria RN; Meric-Bernstam F; Laird PW; Fan JB; Janku F
    Ann Oncol; 2018 Jun; 29(6):1445-1453. PubMed ID: 29635542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Fraction of Circulating Cell-Free DNA as an Indicator of Human Pathology.
    Panagopoulou M; Karaglani M; Tzitzikou K; Kessari N; Arvanitidis K; Amarantidis K; Drosos GI; Gerou S; Papanas N; Papazoglou D; Baritaki S; Constantinidis TC; Chatzaki E
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the Gene Body in
    Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis.
    Yang J; Cheng L; Zhang J; Chen L; Wang D; Guo X; Ma X
    Medicine (Baltimore); 2018 Jul; 97(28):e11417. PubMed ID: 29995790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA.
    Korshunova Y; Maloney RK; Lakey N; Citek RW; Bacher B; Budiman A; Ordway JM; McCombie WR; Leon J; Jeddeloh JA; McPherson JD
    Genome Res; 2008 Jan; 18(1):19-29. PubMed ID: 18032725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.
    Gao Y; Zhou N; Liu J
    Cancer Control; 2024; 31():10732748241255548. PubMed ID: 38764160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles.
    Yasui K; Toshima T; Inada R; Umeda Y; Yano S; Tanioka H; Nyuya A; Fujiwara T; Yamada T; Naomoto Y; Goel A; Nagasaka T
    Mol Cancer; 2024 Jan; 23(1):1. PubMed ID: 38172877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
    Terry MB; McDonald JA; Wu HC; Eng S; Santella RM
    Adv Exp Med Biol; 2016; 882():33-68. PubMed ID: 26987530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating DNA as biomarker in breast cancer.
    Schwarzenbach H; Pantel K
    Breast Cancer Res; 2015 Oct; 17(1):136. PubMed ID: 26453190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.
    Salta S; P Nunes S; Fontes-Sousa M; Lopes P; Freitas M; Caldas M; Antunes L; Castro F; Antunes P; Palma de Sousa S; Henrique R; Jerónimo C
    J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30405052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation signatures of breast cancer in peripheral T-cells.
    Parashar S; Cheishvili D; Mahmood N; Arakelian A; Tanvir I; Khan HA; Kremer R; Mihalcioiu C; Szyf M; Rabbani SA
    BMC Cancer; 2018 May; 18(1):574. PubMed ID: 29776342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
    Fietz S; Diekmann E; de Vos L; Zarbl R; Hunecke A; Glosch AK; Färber M; Sirokay J; Hoffmann F; Fröhlich A; Franzen A; Strieth S; Landsberg J; Dietrich D
    Clin Chem; 2024 Mar; 70(3):516-527. PubMed ID: 38300881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the Z-scan technique for quantifying circulating cell-free DNA (ccfDNA) extracted from blood plasma as a potential biomarker for various cancers.
    Ara H; Tarek SA; Biswas MK; Al-Din SMS; Hoque E; Hasan KME; Hossain AKMM; Faruque SB; Haque Y; Sharafuddin SM
    Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38718773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women.
    Rajkumar T; Amritha S; Sridevi V; Gopal G; Sabitha K; Shirley S; Swaminathan R
    Sci Rep; 2022 Jan; 12(1):100. PubMed ID: 34997107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation Status of Corticotropin-Releasing Factor (CRF) Receptor Genes in Colorectal Cancer.
    Panagopoulou M; Cheretaki A; Karaglani M; Balgkouranidou I; Biziota E; Amarantidis K; Xenidis N; Kakolyris S; Baritaki S; Chatzaki E
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34207031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating nucleic acids as biomarkers in breast cancer.
    Schwarzenbach H
    Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.